Back
Oculis Holding AG 10K Form
Buy
81
OCS
Oculis Holding AG
Last Price:
14.96
Seasonality Move:
10.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OCS News And Ratings
See the #1 stock for the next 7 days that we like better than OCS
OCS Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-14.46M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.01 |
| Price / Book: | 5.32 |
Profitability
| EPS (TTM): | -1.99570 |
|---|---|
| Net Income (TTM): | $-75.28M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Oculis Holding AG Earnings Forecast
Key Oculis Holding AG Financial Ratios
- The Interest Expense is -1.48% of Operating Income.
- Per Share Earnings over the last 4 years have been positive in 0 years.
Oculis Holding AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OCS |
| Website: | oculis.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
OCS Technical Analysis vs Fundamental Analysis
Buy
81
Oculis Holding AG (OCS)
is a Buy
Is Oculis Holding AG a Buy or a Sell?
-
Oculis Holding AG stock is rated a Buy
The current Oculis Holding AG [OCS] share price is $15.99. The Score for OCS is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.